CID Capital
CID Capital is an Indiana-based private equity firm founded in 2006 that specializes in making majority investments in lower-middle-market companies across various industries, including consumer goods, healthcare, leisure, transport, technology, and business services. The firm targets companies with a strong history of performance that have the potential for significant growth but face constraints due to limited capital, inadequate operating systems, or lack of management experience. By providing necessary resources and capital, CID Capital aims to help these companies overcome their challenges and achieve their growth objectives. The firm's current investment strategy includes managing the CID Capital Opportunity Fund III, a buyout fund established in 2022.
Scale Computing, Inc. specializes in edge computing, virtualization, and hyperconverged solutions tailored for midsized businesses. Founded in 2007 and headquartered in Indianapolis, Indiana, the company offers its HC3™ platform, which integrates servers, storage, and virtualization into a single, user-friendly system. This all-in-one appliance enhances storage speed and capacity while simplifying datacenter management. HC3 continuously monitors virtual machines and hardware components to ensure application availability and efficiently address infrastructure events. In addition to its core platform, Scale Computing provides services such as infrastructure refresh, virtual-to-virtual migration, physical-to-virtual migration, and disaster recovery solutions. As a result, the company is increasingly favored by IT departments across various industries looking to maintain high availability and scalability of their applications.
Private Equity Round in 2012
ABC Industries is a maker of ventilation solutions and technical fabrics.
Endocyte, Inc., a biopharmaceutical company, develops receptor-targeted therapeutics to treat cancer and autoimmune/inflammatory diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers of the breast, lung, and blood; EC0225, a targeted chemotherapy drug; BMS753493, a folate-targeted anti-cancer therapy drug; EC0434 to target folate receptor positive tumors; and EC0305, an anti-cancer therapy drug. It also offers EC0286, a folate-targeted small molecule for the treatment of inflammatory diseases; and EC20, a folate-targeted radiopharmaceutical imaging agent to identify folate-receptor positive cancers. The company was founded in 1996 and is based in West Lafayette, Indiana.
Private Equity Round in 2004
Hetsco is synonymous with providing highly skilled, emergency, specialty welding and construction services to the natural gas processing, petrochemical and air gas separation industries. Having completed site repairs across 44 states and more than 35 countries, Hetsco boasts a proud heritage of getting customer plants back on-line quickly and safely.
Private Equity Round in 2004
Maxon manufactures a range of industrial combustion valves, burners, and systems, and has experienced significant growth, which it attributes to its technology and solutions that help customers meet increasing demands around energy efficient operations, increasing environmental regulations and the industrialization of emerging economies.